![Magnus Olafsson Corfitzen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Magnus Olafsson Corfitzen
Directeur Général chez
ASCELIA PHARMA AB
Profil
Magnus Olafsson Corfitzen is currently Chief Executive Officer at Ascelia Pharma AB since 2014.
Also holds director positions at Ascelia Incentive AB and Inventive AB. Former roles include Chief Executive Officer at CMC Contrast AB and Oncoral Pharma ApS, Chairman at FBC Device ApS, Investment Director at Danmarks Eksport- og Investeringsfond, Director at Vivostat A, Investment Director at Sunstone Capital A from 2007 to 2014, Director at DentoFit A, Nordic Vaccine A, Opsona Therapeutics Ltd., and Aro Medical ApS, Principal at McKinsey & Co., Inc., and Portfolio Manager at Danske Bank A and Danske Capital AB. Education includes graduation from the University of Aarhus in 1999.
Postes actifs de Magnus Olafsson Corfitzen
| Sociétés | Poste | Début |
|---|---|---|
| ASCELIA PHARMA AB | Directeur Général | 01/01/2014 |
Ascelia Incentive AB | Directeur/Membre du Conseil | - |
Inventive AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Magnus Olafsson Corfitzen
| Sociétés | Poste | Fin |
|---|---|---|
Oncoral Pharma ApS
 Oncoral Pharma ApS Pharmaceuticals: MajorHealth Technology Provides pharmaceuticals for the treatment of colon and rectal cancer | Directeur Général | 18/11/2021 |
Sunstone Capital A/S
 Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Director of Investments | 30/06/2014 |
DentoFit A/S
 DentoFit A/S Medical SpecialtiesHealth Technology Develops non-shrinking composite resin material for dental plastic fillings | Directeur/Membre du Conseil | 27/01/2014 |
CMC Contrast AB
 CMC Contrast AB Pharmaceuticals: MajorHealth Technology develops magnetic resonance contrast agents for patients suffering with tumors | Directeur Général | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Formation de Magnus Olafsson Corfitzen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
CMC Contrast AB
CMC Contrast AB Pharmaceuticals: MajorHealth Technology develops magnetic resonance contrast agents for patients suffering with tumors | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Danske Bank A/S (Investment Management)
 Danske Bank A/S (Investment Management) Investment ManagersFinance Danske Bank-IM constructs portfolios invested in equity, debt and alternative instruments across strategies and regions with a strong emphasis on European markets. The firm focuses on core investment areas and selects external managers for investments in regions where they do not possess specialist expertise. They seek to identify global trends within traditional and rapidly growing sectors. Danske Bank-IM’s portfolio investment teams employ a bottom-up approach to select equities based on the belief that markets are especially inefficient at pricing companies undergoing change. Their investment process begins with a systematic qualitative and quantitative screening process designed to identify and evaluate companies experiencing or about to experience changes. They then apply their proprietary valuation model, DCF, which is based on fundamental analysis. | Finance |
Danske Capital AB
 Danske Capital AB Investment ManagersFinance Danske Sweden is an active, long-term manager which constructs portfolios invested in European equities, Nordic equities, Eastern European equities and European fixed-income. They focus on core investment areas and select external managers for investments in regions where they do not possess specialist expertise, seeking to identify global trends in traditional and new, fast-growing sectors. The firm's equity investment philosophy follows a bottom-up approach and is based on the belief that markets are inefficient, especially when it comes to pricing companies undergoing changes. Their investment process begins with systematic qualitative and quantitative screening designed to identify and evaluate companies experiencing or about to experience changes. They then apply their proprietary valuation model, DCF, which is based on fundamental analysis. The final step of the process is a comparison of the changes undergone by companies, their quality and their market evaluation. Danske Sweden 's fixed-income investment philosophy also aims to exploit market inefficiencies and consists of a top-down and bottom-up research process combined with quantitative and qualitative analysis. | Finance |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance EIFO invests in small and medium-sized companies located in Denmark. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of equity and debt with an investment size of DKK 5 - 200 million. It also takes a seat on the board of directors. | Finance |
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivostat A/S
 Vivostat A/S Medical SpecialtiesHealth Technology Manufactures and distributes systems for on-site preparation & application of autologous concentrated fibrin and platelet enriched fibrin sealants | Health Technology |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
DentoFit A/S
DentoFit A/S Medical SpecialtiesHealth Technology Develops non-shrinking composite resin material for dental plastic fillings | Health Technology |
Nordic Vaccine A/S
 Nordic Vaccine A/S Pharmaceuticals: MajorHealth Technology Researches, develops and specializes in adjuvants and drug delivery development | Health Technology |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
FBC Device ApS
 FBC Device ApS Medical SpecialtiesHealth Technology Provides spinal implants to improve the treatment of degenerative disc disease | Health Technology |
Aro Medical ApS
 Aro Medical ApS Medical SpecialtiesHealth Technology Provides novel implant for improving outcomes of discectomy surgery in patients with spine herniation | Health Technology |
Oncoral Pharma ApS
Oncoral Pharma ApS Pharmaceuticals: MajorHealth Technology Provides pharmaceuticals for the treatment of colon and rectal cancer | Health Technology |
Ascelia Pharma AB
 Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Ascelia Incentive AB | |
Inventive AB |
